Geralyn P. Kocan

Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease

Srinivasan Nagarajan, Gary A. De Crescenzo, Daniel P. Getman et al. · Bioorganic & Medicinal Chemistry · 2003 · 96 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo

Robin J. Kleiman, Douglas S. Chapin, Curt Christoffersen et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 80 citations

Life Sciences, Neuroscience, Pharmacology +17

Inhibitors of HIV-1 Protease Containing the Novel and Potent (R)-(Hydroxyethyl)sulfonamide Isostere

Michael L. Vazquez, Martin L. Bryant, Michael Clare et al. · Journal of Medicinal Chemistry · 1995 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

P2‐240: PF‐04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non‐clinical species to healthy human volunteers

Timothy Nicholas, Rebecca Evans, Scot Styren et al. · Alzheimer s & Dementia · 2009 · 24 citations

Life Sciences, Neuroscience, Pharmacology +17

Multiple actions of the leukotriene B4 receptor antagonist SC-41930.

Doreen Villani-Price, Daichang Yang, Robin E. Walsh et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 15 citations

Life Sciences, Immunology, Pharmacology +17